Research map: Convalescent plasma for persistent symptomatic COVID-19 infection in immune-suppressed patients – a case series

Back to the article

Papers in this map

  1. An inflammatory cytokine signature predicts COVID-19 severity and survival · Diane Marie Del Valle · 2020 · 2789 citations · Cited by this paper
  2. Repeated measurements of alpha fetoprotein and fibrosis-4 predict long term hepatocellular carcinoma and mortality risks after antiviral therapy · 2026 · Related
  3. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 · Jennifer Hammond · 2022 · 2231 citations · Cited by this paper
  4. The growing impact of nontuberculous mycobacteria: A multidisciplinary review of ecology, pathogenesis, diagnosis, and treatment · 2025 · Related
  5. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host · Bina Choi · 2020 · 1394 citations · Cited by this paper
  6. Comparative analysis of non-invasive fibrosis markers: Insights from chronic HBV, HBV+HDV, and HCV infections · 2025 · Related
  7. SARS-CoV-2 pathogenesis · Mart Matthias Lamers · 2022 · 1028 citations · Cited by this paper
  8. Nontyphoidal Salmonella encephalopathy in a teenager from Hubei, China · 2025 · Related
  9. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis · Adam Booth · 2021 · 571 citations · Cited by this paper
  10. Effect of glycemic control on lymphocyte subsets in the dissemination of pulmonary tuberculosis: A retrospective analysis · 2025 · Related
  11. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer · Teresa Aydillo · 2020 · 442 citations · Cited by this paper
  12. Performance of Xpert MTB/RIF Ultra assay for diagnosis of tuberculosis: A retrospective study in a city with intermediate tuberculosis burden · 2026 · Related
  13. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis · Jennifer G. Wilson · 2020 · 273 citations · Cited by this paper
  14. COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval · 2026 · Related
  15. Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 · Hesham Abdelhady · 2021 · 218 citations · Cited by this paper
  16. Hepatitis E virus and renal injury: A review of pathogenesis, pathology, and clinical management · 2026 · Related
  17. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 · Michael A. Thompson · 2021 · 187 citations · Cited by this paper
  18. Chikungunya outbreak in Guangdong Province, China, 2025 · 2025 · Related
  19. COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis · Jonathon W. Senefeld · 2023 · 175 citations · Cited by this paper
  20. The use of tNGS in the diagnosis of Q fever: A case report and review of cases of liver injury · 2025 · Related
  21. Therapeutic advances in COVID-19 · Naoka Murakami · 2022 · 162 citations · Cited by this paper
  22. COVID-19 in patients with hematologic malignancy · Petra Langerbeins · 2022 · 143 citations · Cited by this paper
  23. SARS-CoV-2 in immunocompromised individuals · Susan DeWolf · 2022 · 138 citations · Cited by this paper
  24. COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes · Daniele Focosi · 2022 · 100 citations · Cited by this paper
  25. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies · Y.-C. Chung · 2024 · 90 citations · Cited by this paper
  26. Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters” · M. Veronica Dioverti · 2022 · 82 citations · Cited by this paper
  27. Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma · Lise J Estcourt · 2022 · 72 citations · Cited by this paper
  28. Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis · Thomas Hueso · 2022 · 68 citations · Cited by this paper
  29. Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019 · Evan M. Bloch · 2023 · 55 citations · Cited by this paper
  30. Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19 · Carolina García‐Vidal · 2021 · 52 citations · Cited by this paper
  31. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview · Igor Vladimirovich Kudryavtsev · 2022 · 52 citations · Cited by this paper
  32. Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial · Matthew G. Johnson · 2023 · 36 citations · Cited by this paper
  33. Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19 · Monika Biernat · 2021 · 33 citations · Cited by this paper
  34. Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS‐CoV‐2 Omicron variants · Yu Wang · 2022 · 33 citations · Cited by this paper
  35. Reasons and consequences of COVID‐19 vaccine failure in patients with chronic lymphocytic leukemia · Marta Morawska · 2021 · 32 citations · Cited by this paper
  36. Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19 · Juan G. Ripoll · 2022 · 29 citations · Cited by this paper
  37. Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management · Suzy E. Meijer · 2024 · 26 citations · Cited by this paper
  38. Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial · Simone Hoffmann · 2025 · 21 citations · Cited by this paper
  39. Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis · Massimo Franchini · 2024 · 19 citations · Cited by this paper

Source: OpenAlex (CC0)